<p>The use of mesenchymal stem cells cultured in the presence of HS-2 for the treatment of bone fracture. Repair of bone fracture using such cells is enhanced compared with the treatment of bone fracture using mesenchymal cells cultured without HS-2. These mesenchymal stem cells may be formulated in a pharmaceutical composition and injected directly into tissues surrounding the fracture or used in a biocompatible implant or prothesis.</p>
申请公布号
WO2011078799(A1)
申请公布日期
2011.06.30
申请号
WO2010SG00481
申请日期
2010.12.22
申请人
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH;COOL, SIMON;NURCOMBE, VICTOR